Dose-finding trial of a combined regimen with bevacizumab, immunotherapy, and chemotherapy in patients with metastatic renal cell cancer: An Italian Oncology Group for Clinical Research (GOIRC) study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples